Excellent response from BLA, albeit hiding behind "investor confidentiality" a bit more than i would have liked.
Very clinical and professional for the most part.
Also, glad to see BLA set the play up for litigation against Glaucus. Well deserved. Shot gun style
Maybe the likes of the media will be a little less accommodating in being used as pawns next time round.
Let's also see if our Corporate Cop, ASIC continues to sit on its hands as spivs wreak havoc on the integrity of the market to the detriment of the loyal investor base. ASIC needs to show the investment community it's serious about protecting investors.
BLA Price at posting:
$10.40 Sentiment: None Disclosure: Not Held
